Login / Signup
Angela Arancio
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Chemotherapy Induced
Community Dwelling
Hiv Positive
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Cecilia Sgadari
,
Biancamaria Scoppio
,
Orietta Picconi
,
Antonella Tripiciano
,
Francesca Maria Gaiani
,
Vittorio Francavilla
,
Angela Arancio
,
Massimo Campagna
,
Clelia Palladino
,
Sonia Moretti
,
Paolo Monini
,
Lucia Brambilla
,
Barbara Ensoli
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Cancer research communications
4 (8) (2024)
Cecilia Sgadari
,
Biancamaria Scoppio
,
Orietta Picconi
,
Antonella Tripiciano
,
Francesca Maria Gaiani
,
Vittorio Francavilla
,
Angela Arancio
,
Massimo Campagna
,
Clelia Palladino
,
Sonia Moretti
,
Paolo Monini
,
Lucia Brambilla
,
Barbara Ensoli
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Cancer research communications
4 (8) (2024)
Cecilia Sgadari
,
Biancamaria Scoppio
,
Orietta Picconi
,
Antonella Tripiciano
,
Francesca Maria Gaiani
,
Vittorio Francavilla
,
Angela Arancio
,
Massimo Campagna
,
Clelia Palladino
,
Sonia Moretti
,
Paolo Monini
,
Lucia Brambilla
,
Barbara Ensoli
Clinical efficacy of the HIV protease-inhibitor Indinavir in combination with chemotherapy for advanced classic Kaposi's sarcoma treatment: a single-arm, phase II trial in the elderly.
Cancer research communications
(2024)